FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes. Anderer S. JAMA 2025 Mar 14. doi: 10.1001/jama.2025.1352.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes. JAMA 2025 Mar 14. doi: 10.1001/jama.2025.1352.
PMID: 40085099